We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+37.58%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$10.5B
AUM Growth
+$2.1B
Cap. Flow
-$429M
Cap. Flow %
-4.09%
Top 10 Hldgs %
13.09%
Holding
245
New
23
Increased
75
Reduced
125
Closed
18

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$64.1M
2
BILL icon
BILL Holdings
BILL
+$53.1M
3
IMMU
Immunomedics Inc
IMMU
+$52.9M
4
ATRC icon
AtriCure
ATRC
+$51.2M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$49.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$120M
2
CBRE icon
CBRE Group
CBRE
+$89.6M
3
CHGG icon
Chegg
CHGG
+$66M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.2M
5
DOX icon
Amdocs
DOX
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 31.1%
2 Healthcare 19.47%
3 Industrials 14.73%
4 Consumer Discretionary 9.8%
5 Financials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HGV icon
126
Hilton Grand Vacations
HGV
$3.01B
$37.5M 0.36%
1,917,457
+94,785
+5% +$1.87M
RPAY icon
127
Repay Holdings
RPAY
$295M
$37.5M 0.36%
1,521,170
-128,250
-8% -$2.59M
ONTO icon
128
Onto Innovation
ONTO
$13.8B
$37.4M 0.36%
1,098,825
+257,670
+31% +$8.38M
EPAY
129
DELISTED
Bottomline Technologies Inc
EPAY
$37.2M 0.36%
733,590
-120,325
-14% -$5.38M
IIIV icon
130
i3 Verticals
IIIV
$280M
$37M 0.35%
1,223,472
-106,620
-8% -$2.71M
WSC icon
131
WillScot Mobile Mini Holdings
WSC
$3.38B
$36.6M 0.35%
2,981,410
+1,071,410
+56% +$13.2M
RPRX icon
132
Royalty Pharma
RPRX
$26.3B
$36.5M 0.35%
+750,800
New +$37.2M
CBRE icon
133
CBRE Group
CBRE
$40.7B
$36.1M 0.34%
797,400
-2,078,700
-72% -$89.6M
OLLI icon
134
Ollie's Bargain Outlet
OLLI
$4.37B
$35.8M 0.34%
366,250
-217,370
-37% -$16.7M
TREE icon
135
LendingTree
TREE
$377M
$35.6M 0.34%
123,025
+455
+0.4% +$110K
SAM icon
136
Boston Beer
SAM
$1.78B
$35M 0.33%
65,310
-44,310
-40% -$21.5M
POOL icon
137
Pool Corp
POOL
$6.29B
$34.9M 0.33%
128,400
-41,700
-25% -$9.65M
HLI icon
138
Houlihan Lokey
HLI
$9.55B
$34.7M 0.33%
623,400
-42,900
-6% -$2.5M
NDSN icon
139
Nordson
NDSN
$17.5B
$34.7M 0.33%
+182,800
New +$31M
AXON
140
Axon Enterprise
AXON
$38.9B
$34.6M 0.33%
352,750
-44,100
-11% -$3.57M
BAND
141
Bandwidth Inc
BAND
$1.83B
$34.2M 0.33%
+269,190
New +$27.2M
ASND icon
142
Ascendis Pharma A/S
ASND
$17.4B
$34M 0.32%
+229,560
New +$31.5M
DCPH
143
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$33.5M 0.32%
560,530
-14,400
-3% -$770K
STE icon
144
Steris
STE
$20.5B
$33.5M 0.32%
+218,100
New +$33.2M
CCMP
145
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$33.5M 0.32%
239,757
+23,802
+11% +$3.08M
SMPL icon
146
Simply Good Foods
SMPL
$870M
$33.3M 0.32%
1,794,330
+165,805
+10% +$2.94M
HUYA
147
Huya Inc
HUYA
$466M
$33M 0.32%
1,769,200
+389,100
+28% +$6.49M
MDLA
148
DELISTED
Medallia, Inc.
MDLA
$32.3M 0.31%
1,279,250
+827,000
+183% +$19.7M
VG
149
DELISTED
Vonage Holdings Corporation
VG
$31.8M 0.3%
+3,162,030
New +$28.4M
FND icon
150
Floor & Decor
FND
$5.13B
$31.4M 0.3%
544,385
-245,920
-31% -$11.2M
4 5
6
7 8

Similar funds

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

TimesSquare Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, TimesSquare Capital Management held 245 positions worth $10.5B, up 25% from $8.39B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $429M in Q2 2020, closing 18 positions and reducing 125 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $56.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in Immunomedics Inc worth $64.2M.

  • TimesSquare Capital Management's largest Q2 2020 buy was Immunomedics Inc: 1,811,000 shares worth $64.2M.
  • TimesSquare Capital Management added most to New Relic, Inc. in Q2 2020, an estimated $64.1M increase.
  • TimesSquare Capital Management's biggest Q2 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $120M.
  • TimesSquare Capital Management fully exited Alexion Pharmaceuticals in Q2 2020, selling an estimated $56.2M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.5B portfolio in Q2 2020.
  • TimesSquare Capital Management opened 23 new positions and closed 18 in Q2 2020.
  • TimesSquare Capital Management's portfolio value rose 25% quarter-over-quarter to $10.5B.

Based on TimesSquare Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.